Disease details

Clinical trials : 3,340 / Drugs : 2,163 - (DrugBank : 383) / Drug target genes : 241 - Drug target pathways : 238

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00623415 (ClinicalTrials.gov)	December 2007	15/2/2008	Flupirtine as Oral Treatment in Multiple Sclerosis	Multicentric, Prospective, Double Blind, Randomized/Stratified, Placebo-controlled Pilot-study for Evaluation of Safety and Efficacy of Flupirtine add-on to Interferon-ß1b on Neurodegeneration in Patients With Relapsing Remitting Multiple Sclerosis	Relapsing Remitting Multiple Sclerosis	Drug: Flupirtine;Drug: Placebo	Charite University, Berlin, Germany	Bayer	Terminated	18 Years	60 Years	All	30	Phase 2	Germany
2	EUCTR2006-005262-39-DE (EUCTR)	30/05/2007	09/03/2007	Flupirtin as Oral Treatment in MS - FLORIMS	Flupirtin as Oral Treatment in MS - FLORIMS	Relapsing-remitting multiple sclerosis	Trade Name: Trancopal Dolo Product Name: Flupirtin INN or Proposed INN: Flupirtin Other descriptive name: Flupirtinmaleat	Charité-Universitätsmedizin Berlin	NULL	Not Recruiting			Female: yes Male: yes	80	Phase 2	Germany